Deferred Tax Assets, Valuation Allowance of Nuvation Bio Inc. from 30 Sep 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Nuvation Bio Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2020 to 31 Dec 2025.
  • Nuvation Bio Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $244,154,000, a 2.5% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Nuvation Bio Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $244,154,000 +$6,009,000 +2.5% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q4 2024 $238,145,000 +$137,664,000 +137% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q4 2023 $100,481,000 +$15,358,000 +18% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q4 2022 $85,123,000 +$30,661,000 +56% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $54,462,000 +$32,714,000 +150% 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q4 2020 $21,748,000 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $154,000* 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.